临床药师参与1例哌拉西林他唑巴坦致药物热抗感染治疗方案调整临床分析

Clinical Pharmacist Participating in the Anti-Infection Treatment of One Patient with Drug Fever Caused by Piperacillin-Tazobactam

目的探讨临床药师在药物热抗感染治疗方案制订中的作用。方法临床药师参与1例哌拉西林他唑巴坦致药物热抗感染治疗过程,经分析二次发热为药物热,找出导致药物热的原因,并根据相关原则重新制订抗感染治疗方案。结果医师采纳临床药师建议,重新制订抗感染治疗方案后,患者未再次发热,感染症状缓解。结论临床药师参与哌拉西林他唑巴坦致药物热的抗感染治疗,保证了疗效,避免了抗菌药物的升级。

Objective To investigate the role of clinical pharmacists in the anti-infection treatment of patients with drug fever caused by piperacillin-tazobactam. Methods The clinical pharmacist participated in 1 case of drug fever anti-infection treatment caused by piperacillin-tazobactam. After analyzing the secondary fever as drug fever,the cause of drug fever was found out,and the anti-infection treatment plan was re-formulated according to relevant principles. Results The physician adopted the clinical pharmacist’s suggestion. After redesigning the anti-infection treatment plan,the patient did not develop fever again and the infection symptoms eased. Conclusion Clinical pharmacists participating in the anti-infection treatment of patients with drug fever caused by piperacillin-tazobactam can ensure the efficacy of treatments and avoid the application upgrade of antibacterial drugs.